183 related articles for article (PubMed ID: 4780239)
1. [Clinical study of tuberactinomycin-N in pulmonary tuberculosis (author's transl)].
Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
Kekkaku; 1973 Oct; 48(10):473-9. PubMed ID: 4780239
[No Abstract] [Full Text] [Related]
2. [Clinical study on tuberactinomycin-N, a new antibiotic].
Osato T; Toyoara M
Kekkaku; 1972 Jun; 47(6):177-80. PubMed ID: 5081206
[No Abstract] [Full Text] [Related]
3. [Comparative study on regimen using tuberactinomycin-N intermittent and daily and viomycin intermittent in combination with rifampicin. The 15th Series-A Study].
Kekkaku; 1973 Apr; 48(4):129-34. PubMed ID: 4124626
[No Abstract] [Full Text] [Related]
4. [Clinical study on tuberactinomycin-N (TUM-N) and viomycin (VM) in retreatment of pulmonary tuberculosis (author's transl)].
Kekkaku; 1974 Jul; 49(7):207-15. PubMed ID: 4372439
[No Abstract] [Full Text] [Related]
5. [Clinical study of a new antibiotic, tuberactinomycin-N, in pulmonary tuberculosis].
Yamamoto K; Aizawa H; Fujita K; Naoe H; Tsuda S
Kekkaku; 1973 Jan; 48(1):23-7. PubMed ID: 4690649
[No Abstract] [Full Text] [Related]
6. [Indications and contraindications for infusion of antibacterial drugs into pulmonary arteries in tuberculosis].
Nizhnikov GI
Probl Tuberk; 1976 Apr; (4):32-5. PubMed ID: 981213
[No Abstract] [Full Text] [Related]
7. [Clinical study on tuberactinomycin, a new antibiotic].
Osato T; Toyoara M
Kekkaku; 1971 May; 46(3):59-63. PubMed ID: 4324041
[No Abstract] [Full Text] [Related]
8. [Clinical study on the therapy of pulmonary tuberculosis with Capreomycin].
Saishin Igaku; 1966 Jan; 21(1):164-77. PubMed ID: 5965936
[No Abstract] [Full Text] [Related]
9. [Clinical use of capromycin in pulmonary tuberculosis].
Zierski M; Bek E
Gruzlica; 1969 Jul; 37(7):649-57. PubMed ID: 4900503
[No Abstract] [Full Text] [Related]
10. [Clinical effect of chemotherapy including minocycline on lung infection due to Mycobacterium avium-Mycobacterium intracellulare (author's transl)].
Tsukamura M; Inoue T; Kuwahara T; Yoshimoto K; Nakajima N
Kekkaku; 1981 Feb; 56(2):57-61. PubMed ID: 7265604
[No Abstract] [Full Text] [Related]
11. [The effects of tuberactinomycin-N (TUM-N) for severe pulmonary tuberculosis (author's transl)].
Miwa T; Tsukamura M; Majima T; Ando Y; Kotetsu Y
Kekkaku; 1975 Aug; 50(8):229-33. PubMed ID: 1195529
[No Abstract] [Full Text] [Related]
12. [Results of treatment with ethambutol and capreomycin in chronic pulmonary tuberculosis].
Kozakow H; Potworowska M; Janowiec M; Klimkiewicz H; Niemirowski J; Pszonicka A; Pecyna-Sielewicz J; Polazek E; Rykowska Z; Frenkel A
Gruzlica; 1969 Jul; 37(7):659-68. PubMed ID: 5350928
[No Abstract] [Full Text] [Related]
13. [Ambulant primary treatment of pulmonary tuberculosis: retrospective analysis of 109 cases followed-up for seven years (author's transl)].
Hu PY
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Dec; 3(4):219-20. PubMed ID: 7297338
[No Abstract] [Full Text] [Related]
14. [Research on primary resistance to antitubercular agents and antibiotics in the antituberculosis centers].
Santi GM; Poggiopollini M
Minerva Med; 1967 Jun; 58(49):2285-8. PubMed ID: 6029301
[No Abstract] [Full Text] [Related]
15. [Studies on the therapeutic effects of lividomycin in retreatment for pulmonary tuberculosis (author's transl)].
Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
Kekkaku; 1974 Jan; 49(1):21-7. PubMed ID: 4827206
[No Abstract] [Full Text] [Related]
16. [Effectiveness of prolonged antibacterial therapy in newly detected patients with active pulmonary tuberculosis].
Kuropatkin IF; Chuprova KP
Probl Tuberk; 1967; 45(9):32-5. PubMed ID: 5606475
[No Abstract] [Full Text] [Related]
17. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
Pines A; Raafat H; Siddiqui GM
J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
[No Abstract] [Full Text] [Related]
18. [Sources of tuberculous infection in the incidence of lung tuberculosis in Middle-Bohemian Region in 1967 (author's transl)].
Véznerová A; Polánský F
Cesk Epidemiol Mikrobiol Imunol; 1974 May; 23(3):150-9. PubMed ID: 4280953
[No Abstract] [Full Text] [Related]
19. [Prevention of residual changes in patients with pulmonary tuberculosis by pathogenetic therapy].
Iakovlev NI
Probl Tuberk; 1977 Dec; (12):46-50. PubMed ID: 609549
[No Abstract] [Full Text] [Related]
20. [Development of pulmonary tuberculosis under the influence of treatment with capreomycin. Clinical and biological considerations].
Viallier MJ; Perrin LF; Cayré RM
Lyon Med; 1966 Nov; 216(47):1169-72 passim. PubMed ID: 5988407
[No Abstract] [Full Text] [Related]
[Next] [New Search]
